Published in Int J Lepr Other Mycobact Dis on June 29, 1968
Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med (1971) 11.44
Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun (1972) 5.12
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med (1975) 4.73
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J (1977) 4.48
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines. Clin Exp Immunol (1971) 3.74
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Experimental lepromatous leprosy. Nature (1967) 3.18
Electron-transparent zone of mycobacteria may be a defence mechanism. Nature (1970) 3.18
Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature (1980) 2.89
Agent transmissible from Crohn's disease tissue. Lancet (1970) 2.89
Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control. Br Med J (1967) 2.84
Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature (1966) 2.63
Interference with normal phagosome-lysosome fusion in macrophages, using ingested yeast cells and suramin. Nature (1975) 2.58
Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol (1968) 2.48
Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis. Infect Immun (1974) 2.43
Mycobacterium tuberculosis in macrophages: effect of certain surfactants and other membrane-active compounds. Science (1968) 2.39
A transmissible agent from sarcoid tissue. Lancet (1969) 2.02
Enhancing effect of antilymphocytic serum on mycobacterial infections in mice. Nature (1968) 1.97
Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol (1983) 1.95
Mycobacteria and lysosomes: a paradox. Nature (1969) 1.95
Manipulations of the phagosome-lysosome fusion response in cultured macrophages. Enhancement of fusion by chloroquine and other amines. Exp Cell Res (1978) 1.91
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Chemotherapy of Tuberculosis-Part II. Br Med J (1946) 1.81
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
Biology of the mycobacterioses. Experimental models for studying leprosy. Ann N Y Acad Sci (1968) 1.78
Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Br J Dermatol (1966) 1.77
The nasal dicharge in leprosy: clinical and bacteriological aspects. Lepr Rev (1974) 1.76
Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet (1994) 1.73
The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol (1973) 1.67
Site of action of a polyanion inhibitor of phagosome-lysosome fusion in cultured macrophages. Exp Cell Res (1980) 1.54
INTRAVITREOUS STREPTOMYCIN: ITS TOXICITY AND DIFFUSION. Br J Ophthalmol (1948) 1.53
Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad. Int J Lepr (1966) 1.53
Human Contagion and Tuberculous Infection in Childhood. Arch Dis Child (1930) 1.47
Experimental and clinical studies on rifampicin in treatment of leprosy. Br Med J (1970) 1.43
Some immunologic aspects of leprosy. Am Rev Respir Dis (1965) 1.41
Urine tests to monitor the self-administration of dapsone by leprosy patients. Am J Trop Med Hyg (1974) 1.39
Chemical inhibitors of phagosome-lysosome fusion in cultured macrophages also inhibit saltatory lysosomal movements. A combined microscopic and computer study. J Exp Med (1983) 1.39
Site of multiplication of human leprosy bacilli inoculated into the foot-pads of mice. Nature (1965) 1.35
Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet (1976) 1.30
The effect of inhibitors and enhancers of phagosome--lysosome fusion in cultured macrophages on the phagosome membranes of ingested yeasts. Exp Cell Res (1979) 1.30
Use of a detergent-acid mixture to rupture tissue culture cells. Nature (1967) 1.29
Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy. Int J Lepr Other Mycobact Dis (1971) 1.28
Lepromin and Kveim antigen reactivity in man, and their relation to tuberculin reactivity. Br Med Bull (1967) 1.27
Early controlled clinical trials. BMJ (1996) 1.23
Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis (1967) 1.23
New prospects for the study of leprosy in the laboratory. Bull World Health Organ (1969) 1.22
Human leprosy in normal mice. Br Med J (1969) 1.22
AIDS and leprosy. Lepr Rev (1988) 1.21
Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Lancet (1975) 1.20
Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin Exp Immunol (1981) 1.18
Studies on sulfone resistance in leprosy. I. Detection of cases. Int J Lepr Other Mycobact Dis (1967) 1.18
Evidence for prevention of borderline leprosy reactions by dapsone. Lancet (1976) 1.15
Serological activity of purified glycolipid from Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1982) 1.12
The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in Northern Malaŵi. I. Methods. Lepr Rev (1987) 1.12
Effect of purification steps on the immunogenicity of Mycobacterium leprae. Br J Exp Pathol (1980) 1.10
Randomised controlled clinical trials. BMJ (1991) 1.09
Formation of antibody against Mycobacterium leprae antigen 7 in armadillos. J Med Microbiol (1978) 1.08
Dapsone acetylation and the treatment of leprosy. Nature (1972) 1.07
Sarcoidosis and Crohn's disease. Proc R Soc Med (1971) 1.06
Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli. Lepr Rev (1974) 1.05
Studies on the determination of the minimal inhibitory concentration of 4,4'-diamino-diphenyl-sulphone (Dapsone, DDS) against Mycobacterium leprae. Lepr Rev (1971) 1.04
Unexpected high incidence of tumours in thymectomized mice treated with anti-lymphocytic globulin and Mycobacterium leprae. Nature (1969) 1.03
Stimulation or inhibition of the respiratory burst in cultured macrophages in a mycobacterium model: initial stimulation is followed by inhibition after phagocytosis. Infect Immun (1994) 1.03
Effects of non-ionic surfactants that modify experimental tuberculosis on lipase activity of macrophages. Br J Pharmacol (1971) 1.02
Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663). Int J Lepr Other Mycobact Dis (1967) 1.02
Macrophage antimicrobial activity: evidence for participation by lysosomes in the killing of Saccharomyces cerevisiae by normal resident macrophages. Infect Immun (1981) 1.00
Airborne infection with Mycobacterium leprae in mice. J Med Microbiol (1977) 0.99
The impact of experimental human leprosy in the mouse on leprosy research. Int J Lepr Other Mycobact Dis (1972) 0.99
Mycobacterium leprae in the striated muscle of patients with leprosy. Lepr Rev (1970) 0.99
Vaccination of mice against Mycobacterium leprae infection. Infect Immun (1989) 0.99
Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Int J Lepr Other Mycobact Dis (1970) 0.98
Leprosy. A preliminary review of the experimental evaluation of drugs for the treatment of leprosy. Trans R Soc Trop Med Hyg (1967) 0.97
The nose in mice with experimental human leprosy. Lepr Rev (1974) 0.96
The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phase. Lepr Rev (1993) 0.96
The place of vaccination in tuberculosis control. Am Rev Respir Dis (1967) 0.96
Adoptive cell transfer of resistance to Mycobacterium leprae infections in mice. Clin Exp Immunol (1985) 0.96
Effects of anionic inhibitors of phagosome-lysosome fusion in cultured macrophages when the ingested organism is Mycobacterium lepraemurium. Infect Immun (1979) 0.96
Transmission of human leprosy to the mouse and its clinical implications. Trans R Soc Trop Med Hyg (1970) 0.95
Peroxidase staining in elicited and nonelicited mononuclear peritoneal cells from BCG-sensitized and nonsensitized mice. Infect Immun (1976) 0.94
Infection of murine striated muscle with Mycobacterium leprae: a study by light and electron microscopy. J Pathol (1972) 0.94
Suppressive effect of homologous and heterologous inflammatory exudate on tuberculin sensitivity in the guinea pig. Am Rev Respir Dis (1970) 0.93
Suggested role of lysosomal lipid in the contrasting effects of 'triton WR-1339' and dextran on tuberculous infection. Nature (1969) 0.92
Outbreak of Paederus dermatitis in southern Nigeria. Epidemiology and dermatology. Int J Dermatol (1990) 0.92
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies. Int J Lepr Other Mycobact Dis (1976) 0.90
Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD. Clin Exp Immunol (1978) 0.89
Experimental studies on nerve fibers in leprosy. II. The reaction of human Schwann cells toward particles and leprosy bacilli. Int J Lepr (1968) 0.89
Dapsone metabolism in patients with dapsone-resistant leprosy. Am J Trop Med Hyg (1975) 0.89
BCG vaccination in mycobacterial infections. Br Med Bull (1969) 0.88
Is the Kveim test safe? Lancet (1971) 0.88
Further observations on the transmissibility of Crohn's disease. Ann N Y Acad Sci (1976) 0.88
Defects in the blood-nerve barrier in mice with leprosy neuropathy. Nat New Biol (1972) 0.87
Tubular lysosomes and their drug reactivity in cultured resident macrophages and in cell-free medium. Exp Cell Res (1990) 0.87
The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves. Br J Pharmacol (1975) 0.87
The fate of Mycobacterium leprae in CBA mice. J Pathol (1971) 0.87
The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients. Lepr Rev (1988) 0.86
The histopathology of lepromatous leprosy in the nose. J Pathol (1975) 0.86
Dapsone-resistant leprosy in Ethiopia. Lepr Rev (1979) 0.85